TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 3 Multicenter, RandomizeEd, Double Blind, Placebo COntrolled, Parallel Group Study to Evaluate the Safety, Tolerability, & Efficacy of SER-109 vs. Placebo to Reduce Recurrence of ClOstRidium Difficile Infection (CDI) in Adults
Brief Summary: Subjects will receive an oral dose of SER-109 in 4 capsules once daily for 3 consecutive days in Treatment Group I or matching placebo once daily for 3 consecutive days in Treatment Group II. The purpose of this study is to demonstrate the superiority of SER-109 vs placebo to reduce recurrence of CDI as determined by a toxin assay in adults up to 8 weeks after initiation of treatment.


Options:
A: Arm Label: Control; Type: SHAM_COMPARATOR; Interventions: Biological: Placebo | Arm Label: Treatment; Type: EXPERIMENTAL; Interventions: Biological: Fecal Microbiota Transplant | Intervention Type: BIOLOGICAL; Name: Fecal Microbiota Transplant; Assigned to Arm(s): Treatment | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Control
B: Arm Label: Fecal Microbiota Transplantation; Type: ACTIVE_COMPARATOR; Interventions: Biological: Fecal Microbiota Transplantation | Arm Label: Sham Fecal Microbiota Transplantation; Type: SHAM_COMPARATOR; Interventions: Biological: Sham Fecal Microbiota Transplantation | Intervention Type: BIOLOGICAL; Name: Fecal Microbiota Transplantation; Assigned to Arm(s): Fecal Microbiota Transplantation | Intervention Type: BIOLOGICAL; Name: Sham Fecal Microbiota Transplantation; Assigned to Arm(s): Sham Fecal Microbiota Transplantation
C: Arm Label: Fecal Transplantation; Type: EXPERIMENTAL; Interventions: Other: Fecal Transplantation | Arm Label: Sham Transplantation; Type: SHAM_COMPARATOR; Interventions: Other: Sham Transplantation | Intervention Type: OTHER; Name: Fecal Transplantation; Assigned to Arm(s): Fecal Transplantation | Intervention Type: OTHER; Name: Sham Transplantation; Assigned to Arm(s): Sham Transplantation
D: Arm Label: SER-109; Type: EXPERIMENTAL; Interventions: Biological: SER-109 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: BIOLOGICAL; Name: SER-109; Assigned to Arm(s): SER-109 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Non-alcoholic Fatty Liver Disease (NAFLD) in Overweight and Obese People Under Nutritional and Lifestyle Follow-up: a Randomized Controlled Trial
Brief Summary: Non-alcoholic fatty liver disease (NAFLD) is a condition of excessive hepatic lipid accumulation in subjects that consume less than 20g ethanol per day, without other known causes as drugs consumption or toxins exposure. In Western countries, the rate of this disease lies about 30% in the general adult population. The process of developing NAFLD can start from simple steatosis to non-alcoholic steatohepatitis (NASH), which eventually can lead to cirrhosis and hepatocellular carcinoma in the absence of alcohol abuse. Liver biopsy is considered the "gold standard" of steatosis, fibrosis and cirrhosis. However, it is rarely performed because it is an invasive procedure and investigators are focusing in the application of non-invasive liver damage scores for diagnosis.

The pathogenesis of NAFLD is multifactorial and triggered by environmental factors such as unbalanced diets and overnutrition as well as by lack of physical activity in the context of a genetic predisposition. Nowadays, the treatment of NAFLD is based on diet and lifestyle modifications. Weight loss, exercise and healthy eating habits are the main tools to fight NAFLD. Nevertheless, there is no a well characterized dietary pattern and further studies are necessary.

With this background, the general aim of this project is to increase the knowledge on the influence of nutritional/lifestyle interventions in obese patients with NAFLD, as well as contribute to identify non-invasive biomarkers/scores to early diagnosis of this pathology in future obese people.


Options:
A: Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Exercise; Type: EXPERIMENTAL; Interventions: Behavioral: exercise | Intervention Type: BEHAVIORAL; Name: exercise; Assigned to Arm(s): Exercise
B: Arm Label: Control; Type: EXPERIMENTAL; Interventions: Behavioral: Unsupervised exercise training | Arm Label: lifestyle counseling and exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Supervised exercise training | Intervention Type: BEHAVIORAL; Name: Unsupervised exercise training; Assigned to Arm(s): Control | Intervention Type: BEHAVIORAL; Name: Supervised exercise training; Assigned to Arm(s): lifestyle counseling and exercise
C: Arm Label: Glucose; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Glucose | Arm Label: Fructose; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Fructose | Intervention Type: DIETARY_SUPPLEMENT; Name: Glucose; Assigned to Arm(s): Glucose | Intervention Type: DIETARY_SUPPLEMENT; Name: Fructose; Assigned to Arm(s): Fructose
D: Arm Label: Control diet; Type: PLACEBO_COMPARATOR; Interventions: Other: Control diet | Arm Label: FLiO diet; Type: EXPERIMENTAL; Interventions: Other: FLiO diet | Intervention Type: OTHER; Name: Control diet; Assigned to Arm(s): Control diet | Intervention Type: OTHER; Name: FLiO diet; Assigned to Arm(s): FLiO diet

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Person-centred Care at Distance for Persons With Chronic Heart Failure (CHF) and/or Chronic Obstructive Pulmonary Disease (COPD)
Brief Summary: The goal of the research project PROTECT is to translate the Person-Centred Care (PCC) principles into an eHealth (the use of information and communication technologies for health) context. A developed PCC eHealth platform will be used as a tool to identify patients´ resources to enhance coping and living with their chronic illness by means of a dialog and partnership with staff and relatives. The PCC eHealth platform will not replace, but instead be used as add on treatment to usual care (guideline directed care).


Options:
A: Arm Label: Health Coaching; Type: EXPERIMENTAL; Interventions: Behavioral: Health Coaching | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Health Coaching; Assigned to Arm(s): Health Coaching
B: Arm Label: Self-Control; Type: ACTIVE_COMPARATOR; Interventions: Other: Ergometer Training | Arm Label: Motivation; Type: EXPERIMENTAL; Interventions: Other: Ergometer Training, Other: Motivation | Intervention Type: OTHER; Name: Ergometer Training; Assigned to Arm(s): Motivation, Self-Control | Intervention Type: OTHER; Name: Motivation; Assigned to Arm(s): Motivation
C: Arm Label: Intervention--PACT Intensive Management; Type: EXPERIMENTAL; Interventions: Behavioral: PACT Intensive Management | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: PACT Intensive Management; Assigned to Arm(s): Intervention--PACT Intensive Management
D: Arm Label: Person-centred care at distance; Type: EXPERIMENTAL; Interventions: Behavioral: Person-centred care at distance | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Person-centred care at distance; Assigned to Arm(s): Person-centred care at distance

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Stroke - 65 Plus. Continued Active Life. A Randomised Controlled Trial of the Effect of a Novel Self-management Intervention Supporting Older Adults After Stroke
Brief Summary: Since august 2016, the researchers at a highly specialized neurorehabilitation hospital in a Danish region with 1.2 inhabitants have in cooperation with health professionals from a specialized neurorehabilitation in a Danish municipality with 336,000 inhabitants, worked through and is still working with an iterative process in the development of a novel self-management support intervention for elderly stroke individuals.The intervention is going to be implemented into the second phase- a randomized clinical controlled trial (RCT) in the project named 'Stroke - 65 plus. Continued active life'.


Options:
A: Arm Label: Mentor; Type: EXPERIMENTAL; Interventions: Behavioral: Mentor | Arm Label: Traditional rehabilitation; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Mentor | Intervention Type: BEHAVIORAL; Name: Mentor; Assigned to Arm(s): Mentor, Traditional rehabilitation
B: Arm Label: sequential training group (SEQ); Type: EXPERIMENTAL; Interventions: Behavioral: aerobic exercise training, Behavioral: cognitive training | Arm Label: control intervention group (CI); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: control training | Intervention Type: BEHAVIORAL; Name: aerobic exercise training; Assigned to Arm(s): sequential training group (SEQ) | Intervention Type: BEHAVIORAL; Name: control training; Assigned to Arm(s): control intervention group (CI) | Intervention Type: BEHAVIORAL; Name: cognitive training; Assigned to Arm(s): sequential training group (SEQ)
C: Arm Label: Robot group; Type: EXPERIMENTAL; Interventions: Device: robot-assisted neurocognitive therapy of hand function | Arm Label: Control group; Type: ACTIVE_COMPARATOR; Interventions: Other: Conventional neurocognitive rehabilitation | Intervention Type: DEVICE; Name: robot-assisted neurocognitive therapy of hand function; Assigned to Arm(s): Robot group | Intervention Type: OTHER; Name: Conventional neurocognitive rehabilitation; Assigned to Arm(s): Control group
D: Arm Label: animal assisted therapy; Type: EXPERIMENTAL; Interventions: Other: animal assisted therapy | Arm Label: standard therapy; Type: ACTIVE_COMPARATOR; Interventions: Other: standard therapy | Intervention Type: OTHER; Name: animal assisted therapy; Assigned to Arm(s): animal assisted therapy | Intervention Type: OTHER; Name: standard therapy; Assigned to Arm(s): standard therapy

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Treatment of Cervical Syndrome With Myofascial Therapies
Brief Summary: This study aimed to investigate the effects of myofascial release therapy (MRT) for improving pressure pain thresholds (PPTs), range of motion and pain in patients with mechanical neck pain (NP).


Options:
A: Arm Label: Waiting list control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Treatment group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Dry Cupping or fire cupping | Intervention Type: PROCEDURE; Name: Dry Cupping or fire cupping; Assigned to Arm(s): Treatment group
B: Arm Label: Massage Dose 1; Type: EXPERIMENTAL; Interventions: Other: Massage | Arm Label: Massage - Dose 2; Type: EXPERIMENTAL; Interventions: Other: Massage | Arm Label: Massage - Dose 3; Type: EXPERIMENTAL; Interventions: Other: Massage | Arm Label: Massage - Dose 4; Type: EXPERIMENTAL; Interventions: Other: Massage | Arm Label: Massage - Dose 5; Type: EXPERIMENTAL; Interventions: Other: Massage | Arm Label: Massage - Dose 6; Type: EXPERIMENTAL; Interventions: Other: Massage | Intervention Type: OTHER; Name: Massage; Assigned to Arm(s): Massage - Dose 2, Massage - Dose 3, Massage - Dose 4, Massage - Dose 5, Massage - Dose 6, Massage Dose 1
C: Arm Label: EXPERIMENTAL GROUP; Type: EXPERIMENTAL; Interventions: Procedure: Physiotherapy treatment | Arm Label: CONTROL GROUP; Type: EXPERIMENTAL; Interventions: Procedure: Physiotherapy treatment | Intervention Type: PROCEDURE; Name: Physiotherapy treatment; Assigned to Arm(s): EXPERIMENTAL GROUP | Intervention Type: PROCEDURE; Name: Physiotherapy treatment; Assigned to Arm(s): CONTROL GROUP
D: Arm Label: Mobilization Group; Type: EXPERIMENTAL; Interventions: Other: translational dorsal glide mobilization technique grade III, Other: Control Group | Arm Label: Maintained pressure Group; Type: EXPERIMENTAL; Interventions: Other: pressure maintained suboccipital Inhibition technique, Other: Control Group | Arm Label: Control Group; Type: OTHER; Interventions: Other: Control Group | Intervention Type: OTHER; Name: translational dorsal glide mobilization technique grade III; Assigned to Arm(s): Mobilization Group | Intervention Type: OTHER; Name: pressure maintained suboccipital Inhibition technique; Assigned to Arm(s): Maintained pressure Group | Intervention Type: OTHER; Name: Control Group; Assigned to Arm(s): Control Group, Maintained pressure Group, Mobilization Group

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Histological Improvement of Non-alcoholic Steatohepatitis With a Prebiotic: a Pilot Clinical Trial
Brief Summary: This trial will investigate the therapeutic potential of a prebiotic supplement to improve histological parameters of NASH. In a single-blind, placebo controlled, randomized pilot trial will be conduced in individuals with liver biopsy confirmed NASH (Non-alcoholic fatty liver activity score (NAS) ≥ 5). Participants will be randomized to receive oligofructose (8 g/day for 12 weeks and 16g/day for 24 weeks) or isocaloric placebo for 9 months. The primary outcome measure is the change in liver biopsy NAS score and the secondary outcomes include changes in body weight, body composition, glucose tolerance, serum lipids, inflammatory markers, and gut microbiota.


Options:
A: Arm Label: Control; Type: EXPERIMENTAL; Interventions: Behavioral: Unsupervised exercise training | Arm Label: lifestyle counseling and exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Supervised exercise training | Intervention Type: BEHAVIORAL; Name: Unsupervised exercise training; Assigned to Arm(s): Control | Intervention Type: BEHAVIORAL; Name: Supervised exercise training; Assigned to Arm(s): lifestyle counseling and exercise
B: Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Arm Label: Omega-3 carboxylic acids 4g / day; Type: EXPERIMENTAL; Interventions: Drug: Omega-3 carboxylic acids | Arm Label: Dapagliflozin, 10mg / day; Type: EXPERIMENTAL; Interventions: Drug: Dapagliflozin | Arm Label: Omega-3 carboxylic acids 4g/day+Dapagliflozin 10mg/day; Type: EXPERIMENTAL; Interventions: Drug: Omega-3 carboxylic acids, Drug: Dapagliflozin | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): placebo | Intervention Type: DRUG; Name: Omega-3 carboxylic acids; Assigned to Arm(s): Omega-3 carboxylic acids 4g / day, Omega-3 carboxylic acids 4g/day+Dapagliflozin 10mg/day | Intervention Type: DRUG; Name: Dapagliflozin; Assigned to Arm(s): Dapagliflozin, 10mg / day, Omega-3 carboxylic acids 4g/day+Dapagliflozin 10mg/day | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): placebo
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Metformin | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Vitamin E | Arm Label: 3; Type: PLACEBO_COMPARATOR; Interventions: Drug: Matching placebo | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): 1 | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin E; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Matching placebo; Assigned to Arm(s): 3
D: Arm Label: Prebiotic; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Prebiotic oligofructose | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo maltodextrin | Intervention Type: DIETARY_SUPPLEMENT; Name: Prebiotic oligofructose; Assigned to Arm(s): Prebiotic | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo maltodextrin; Assigned to Arm(s): Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Multi-center Clinical Trials of Thalidomide in TI
Brief Summary: This is an exploratory experiment, aims to explore the effective and safety of thalidomide in the treatment of TI to improve the hemoglobin level, improve the quality of life, reduce blood transfusion, so as to avoid the adverse reactions caused by transfusion,60\~100 patients will be enrolled.


Options:
A: Arm Label: thalidomide thalassemia; Type: EXPERIMENTAL; Interventions: Drug: Thalidomide | Intervention Type: DRUG; Name: Thalidomide; Assigned to Arm(s): thalidomide thalassemia
B: Arm Label: thalidomide thalassemia; Type: EXPERIMENTAL; Interventions: Drug: Thalidomide | Intervention Type: DRUG; Name: Thalidomide; Assigned to Arm(s): thalidomide thalassemia
C: Arm Label: Hydroxyurea,blood transfusion; Type: ACTIVE_COMPARATOR; Interventions: Drug: hydroxyurea, blood transfusion | Arm Label: Hydroxyurea, Epiao; Type: EXPERIMENTAL; Interventions: Drug: Hydroxyurea ,Epiao | Intervention Type: DRUG; Name: Hydroxyurea ,Epiao; Assigned to Arm(s): Hydroxyurea, Epiao | Intervention Type: DRUG; Name: hydroxyurea, blood transfusion; Assigned to Arm(s): Hydroxyurea,blood transfusion
D: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Drug: Colla corii asini | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Colla corii asini; Assigned to Arm(s): Intervention group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: iLook Out for Child Abuse: An Innovative Learning Module for Childcare Providers
Brief Summary: This five-year study aims to improve childcare provider (CCP) reporting of suspected child abuse by means of an online learning module, iLook Out for Child Abuse. Using an interactive, video-based story-line (along with follow-up activities), iLookOut engages CCPs emotionally and intellectually to take the first step in addressing the epidemic of child abuse -which in the U.S. claims \>680,000 confirmed victims annually. The consequences of child abuse can be devastating and long-lasting. The purpose of this study is to establish an evidence-based intervention that can help those who care for young children recognize and report suspected child abuse before irreparable harm occurs.


Options:
A: Arm Label: iLook Out for Child Abuse; Type: EXPERIMENTAL; Interventions: Other: iLook Out for Child Abuse | Intervention Type: OTHER; Name: iLook Out for Child Abuse; Assigned to Arm(s): iLook Out for Child Abuse
B: Arm Label: interactive lecture module; Type: ACTIVE_COMPARATOR; Interventions: Other: interactive lecture | Arm Label: online educational module; Type: ACTIVE_COMPARATOR; Interventions: Other: online education | Intervention Type: OTHER; Name: interactive lecture; Assigned to Arm(s): interactive lecture module | Intervention Type: OTHER; Name: online education; Assigned to Arm(s): online educational module
C: Arm Label: iLookOut; Type: EXPERIMENTAL; Interventions: Other: iLook Out for Child Abuse | Arm Label: Standard; Type: ACTIVE_COMPARATOR; Interventions: Other: iLook Out for Child Abuse | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: iLook Out for Child Abuse; Assigned to Arm(s): Standard, iLookOut
D: Arm Label: E-learning program; Type: N/A; Interventions: Other: E-learning program | Arm Label: control group; Type: N/A; Interventions: N/A | Intervention Type: OTHER; Name: E-learning program; Assigned to Arm(s): E-learning program

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: System-integrated Technology-enabled Model of Care to Improve the Health of Stroke Patients in Rural China
Brief Summary: Despite the significant burden of stroke in rural China, secondary prevention of stroke is scarce. The aim of the study is to develop a system-integrated technology-enabled intervention (SINEMA) model for the secondary prevention of stroke in rural China and evaluate the effectiveness of the model compared with usual care. The hypothesis is that trained village doctors, equipped with digital health technology, can provide essential evidence-based care to stroke survivors in rural China.


Options:
A: Arm Label: Intervention SMS; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Intervention SMS | Arm Label: Control SMS; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Control SMS | Intervention Type: BEHAVIORAL; Name: Intervention SMS; Assigned to Arm(s): Intervention SMS | Intervention Type: BEHAVIORAL; Name: Control SMS; Assigned to Arm(s): Control SMS
B: Arm Label: Mobile App Group; Type: EXPERIMENTAL; Interventions: Other: Daily reminders of taking medications, Other: Educational materials | Arm Label: Control Group; Type: ACTIVE_COMPARATOR; Interventions: Other: Educational materials | Intervention Type: OTHER; Name: Daily reminders of taking medications; Assigned to Arm(s): Mobile App Group | Intervention Type: OTHER; Name: Educational materials; Assigned to Arm(s): Control Group, Mobile App Group
C: Arm Label: SINEMA intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: SINEMA intervention | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: SINEMA intervention; Assigned to Arm(s): SINEMA intervention group
D: Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Generic Nudge; Type: EXPERIMENTAL; Interventions: Behavioral: Nudge | Arm Label: Optimized nudge; Type: EXPERIMENTAL; Interventions: Behavioral: Nudge | Arm Label: Optimized nudge plus AI Chat Bot; Type: EXPERIMENTAL; Interventions: Behavioral: Nudge | Intervention Type: BEHAVIORAL; Name: Nudge; Assigned to Arm(s): Generic Nudge, Optimized nudge, Optimized nudge plus AI Chat Bot

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: System-integrated Technology-enabled Model of Care to Improve the Health of Stroke Patients in Rural China
Brief Summary: Despite the significant burden of stroke in rural China, secondary prevention of stroke is scarce. The aim of the study is to develop a system-integrated technology-enabled intervention (SINEMA) model for the secondary prevention of stroke in rural China and evaluate the effectiveness of the model compared with usual care. The hypothesis is that trained village doctors, equipped with digital health technology, can provide essential evidence-based care to stroke survivors in rural China.


Options:
A: Arm Label: mWELLCARE software arm; Type: EXPERIMENTAL; Interventions: Other: mWELLCARE | Arm Label: Usual care arm; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual Care | Intervention Type: OTHER; Name: mWELLCARE; Assigned to Arm(s): mWELLCARE software arm | Intervention Type: OTHER; Name: Usual Care; Assigned to Arm(s): Usual care arm
B: Arm Label: without CDSS; Type: NO_INTERVENTION; Interventions: Other: CDSS | Arm Label: with CDSS; Type: EXPERIMENTAL; Interventions: Other: CDSS | Intervention Type: OTHER; Name: CDSS; Assigned to Arm(s): with CDSS, without CDSS
C: Arm Label: SINEMA intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: SINEMA intervention | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: SINEMA intervention; Assigned to Arm(s): SINEMA intervention group
D: Arm Label: Intervention districts; Type: EXPERIMENTAL; Interventions: Other: Maternal and neonatal emergency protocols | Arm Label: Control districts; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Maternal and neonatal emergency protocols; Assigned to Arm(s): Intervention districts

Answer: C